TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
EXEL

Exelixis Inc

Healthcare · Biotechnology

58.30$ -0.9% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Cash Flow

Exelixis Inc (EXEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 308 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EXEL
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
-6.4 84 69 5.5 38 53 72 75 165 105 162 132 76 158 56 102 18 33 40 182 83 96 148 31 110 74 84 121 117 11 69 120 271 240 211 49 290 334 252 308 1,183
0.3 0.2 0.3 0.3 0.3 0.3 0.4 0.8 1.7 4.9 -5.8 2.7 2.8 8.6 2.2 2.2 2.4 2.4 3.2 3.7 4.8 1.9 4.5 4.8 5.7 5.9 6.9 6.0 6.3 6.5 6.4 7.3 7.5 7.6 7.3 7.3 7.4 6.9 6.9 7.0 28
3.6 4.6 4.7 5.0 5.3 8.9 9.3 12 10 13 15 16 14 12 14 16 56 19 35 28 34 23 20 25 37 26 17 25 40 24 19 25 23 26 26 36 31 20 29 33 113
5.6 7.5 -2.8 3.3 9.0 11 7.1 8.8 -233 11 46 35 40 23 – 30 21 39 72 58 26 38 17 46 46 71 49 -16 135 – – – – – – – – – – – –
-14 43 44 -9.7 -47 5.6 -55 -23 27 -28 78 3.0 -61 47 -19 1.0 -3.1 -19 -4.3 9.9 -18 -27 37 -61 -15 27 -19 5.0 -25 24 -29 -146 58 104 17 -180 45 -73 -0.6 43 14
0.0 0.6 0.8 1.5 1.1 18 2.9 12 15 2.9 2.3 1.2 2.1 7.3 3.0 7.0 6.1 14 14 20 14 16 5.6 12 8.0 112 49 7.4 94 13 18 25 9.2 14 22 3.6 6.7 7.2 2.0 9.3 25
-12 -60 35 47 -27 -19 -26 -66 -63 -143 -108 -143 -206 -130 33 73 -208 -30 62 -71 -21 -13 -75 -135 -69 -246 -50 -74 35 62 112 82 -217 -93 50 248 25 27 -51 91 93
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
-0.7 -1.4 -1.5 -0.8 -0.7 -3.6 -2.1 -0.8 -0.2 -4.4 -1.6 -0.9 -0.9 -6.5 -1.8 -19 -5.2 -24 -5.4 -4.0 -5.6 -24 -4.7 -6.5 -4.9 24 -2.6 -124 -217 -209 -185 -264 -12 -190 -284 -302 -104 -258 -430 -323 -1,115
-0.6 -80 -106 -0.3 -186 -0.3 -0.3 0.3 0.3 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 17 -72 -100 2.9 -0.7 -0.3 7.2 3.9 -1.1 5.2 7.1 3.3 -3.0 2.1 -5.1 -3.4 -19 -2.7 8.7 -2.9 -18 0.2 4.4 -2.0 -2.0 4.6 -125 -220 -206 -184 -262 5.7 -188 -295 -316 -104 -255 -457 -344 -1,159
-19 40 31 -48 14 34 46 16 105 -39 59 -4.1 -128 25 91 170 -193 -15 99 119 59 65 73 -100 39 -174 39 -78 -68 -134 -3.4 -61 60 -41 -34 -19 212 106 -256 55 117
-6.5 83 68 4.0 37 36 69 63 149 102 159 131 74 151 53 95 12 19 26 161 69 80 142 19 102 -39 36 114 23 -2.6 51 95 262 226 189 45 284 326 250 298 1,158

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?